Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

H Tian, J Cao, B Li, EC Nice, H Mao, Y Zhang… - Bone Research, 2023 - nature.com
Osteosarcoma, with poor survival after metastasis, is considered the most common primary
bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival …

Myeloid cells in sepsis‐acquired immunodeficiency

F Venet, J Demaret, M Gossez… - Annals of the New York …, 2021 - Wiley Online Library
Abstract On May 2017, the World Health Organization recognized sepsis as a global health
priority. Sepsis profoundly perturbs immune homeostasis by initiating a complex response …

Recent advances in monoclonal antibody-based approaches in the management of bacterial sepsis

K Kharga, L Kumar, SKS Patel - Biomedicines, 2023 - mdpi.com
Sepsis is a life-threatening condition characterized by an uncontrolled inflammatory
response to an infectious agent and its antigens. Immune cell activation against the antigens …

Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs

RV Brady, DH Thamm - Frontiers in Immunology, 2023 - frontiersin.org
Macrophages are ancient, phagocytic immune cells thought to have their origins 500 million
years ago in metazoan phylogeny. The understanding of macrophages has evolved to …

Contribution of dendritic cell responses to sepsis-induced immunosuppression and to susceptibility to secondary pneumonia

M Bouras, K Asehnoune, A Roquilly - Frontiers in immunology, 2018 - frontiersin.org
Dendritic cells (DCs) are bone marrow derived cells which continuously seed in peripheral
tissue. During infection, DCs play an essential interface between innate and adaptive …

PD-1 signaling pathway in sepsis: Does it have a future?

R Chen, L Zhou - Clinical Immunology, 2021 - Elsevier
Sepsis is characterized by high mortality and poor prognosis and is one of the leading
causes of death among patients in the intensive care unit (ICU). In the past, drugs that block …

[HTML][HTML] Prolonged reactive oxygen species production following septic insult

IJ Jensen, PW McGonagill, RR Berton, BA Wagner… - …, 2021 - journals.aai.org
The dysregulated host response and organ damage following systemic infection that
characterizes a septic event predisposes individuals to a chronic immunoparalysis state …

[HTML][HTML] Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell …

A Kumar, V Ramani, V Bharti… - … for Immunotherapy of …, 2023 - ncbi.nlm.nih.gov
Background Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) combined with endocrine
therapy are a mainstay treatment for hormone receptor-positive breast cancer. While their …

The protective effects and the involved mechanisms of tanshinone IIA on sepsis-induced brain damage in mice

C Xiong, H Zhou, J Wu, NZ Guo - Inflammation, 2019 - Springer
To evaluate the protective effect of tanshinone IIA on sepsis using a mouse model as well as
to preliminarily explore the mechanism behind its application. The mouse model of sepsis …

Mitochondria‐derived damage‐associated molecular patterns in sepsis: from bench to bedside

S Li, Q Hu, J Huang, X Wu, J Ren - Oxidative medicine and …, 2019 - Wiley Online Library
Sepsis is one of the most serious health hazards. Current research suggests that the
pathogenesis of sepsis is mediated by both pathogen‐associated molecular patterns …